|
1
|
Nathan SD, Barbera JA, Gaine SP, Harari S,
Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J,
Provencher S, et al: Pulmonary hypertension in chronic lung disease
and hypoxia. Eur Respir J. 53(1801914)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
King CS and Shlobin OA: The trouble with
group 3 pulmonary hypertension in interstitial lung disease:
Dilemmas in diagnosis and the conundrum of treatment. Chest.
158:1651–1664. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hamada K, Nagai S, Tanaka S, Handa T,
Shigematsu M, Nagao T, Mishima M, Kitaichi M and Izumi T:
Significance of pulmonary arterial pressure and diffusion capacity
of the lung as prognosticator in patients with idiopathic pulmonary
fibrosis. Chest. 131:650–656. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kimura M, Taniguchi H, Kondoh Y, Kimura T,
Kataoka K..Nishiyama O, Aso H, Sakamoto K and Hasegawa Y: Pulmonary
hypertension as a prognostic indicator at the initial evaluation in
idiopathic pulmonary fibrosis. Respiration. 85:456–463.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nathan SD, Shlobin OA, Ahmad S, Koch J,
Barnett SD, Ad N, Burton N and Leslie K: Serial development of
pulmonary hypertension in patients with idiopathic pulmonary
fibrosis. Respiration. 76:288–294. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Minai OA, Santacruz JF, Alster JM, Budev
MM and McCarthy K: Impact of pulmonary hemodynamics on 6-min walk
test in idiopathic pulmonary fibrosis. Respir Med. 106:1613–1621.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nathan SD, Shlobin OA, Barnett SD, Saggar
R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP III
and Zisman DA: Right ventricular systolic pressure by
echocardiography as a predictor of pulmonary hypertension in
idiopathic pulmonary fibrosis. Respir Med. 102:1305–1310.
2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Walter K: Pulmonary hypertension. JAMA.
326(1116)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lv GJ, Li AL, Tao XC, Zhai YN, Zhang Y,
Lei JP, Gao Q, Xie WM and Zhai ZG: The accuracy and influencing
factors of Doppler echocardiography in estimating pulmonary artery
systolic pressure: comparison with right heart catheterization: A
retrospective cross-sectional study. BMC Med Imaging.
22(91)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rudski LG, Lai WW, Afilalo J, Hua L,
Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK and
Schiller NB: Guidelines for the echocardiographic assessment of the
right heart in adults: A report from the American society of
echocardiography endorsed by the European association of
echocardiography, a registered branch of the European society of
cardiology, and the Canadian society of Echocardiography. J Am Soc
Echocardiogr. 23:685–713; quiz 786-8. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kendall M: Multivariate analysis. Charles
Griffin, London, 1975.
|
|
12
|
Li N: Current status and influencing
factors of feeding intolerance in patients with severe nervous
system diseases (unpublished thesis). Lanzhou University, 2021.
|
|
13
|
Huang YK: Clinical characteristics and
risk factors of pulmonary hypertension secondary to connective
tissue disease-related interstitial lung disease (unpublished
thesis). Health Science Center of Nanchang University, 2023.
|
|
14
|
Travis WD, Costabel U, Hansell DM, King TE
Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU,
et al: ATS/ERS Committee on idiopathic interstitial pneumonias. An
official American thoracic society/European respiratory society
statement: Update of the international multidisciplinary
classification of the idiopathic interstitial pneumonias. Am J
Respir Crit Care Med. 188:733–748. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kay J and Upchurch KS: ACR/EULAR 2010
rheumatoid arthritis classification criteria. Rheumatology
(Oxford). 51 (Suppl 6):vi5–vi9. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aringer M, Costenbader K, Daikh D, Brinks
R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen
DL, et al: 2019 European league against rheumatism/American college
of rheumatology classification criteria for systemic lupus
erythematosus. Ann Rheum Dis. 78:1151–1159. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
van den Hoogen F, Khanna D, Fransen J,
Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP,
Medsger TA Jr, Carreira PE, et al: 2013 classification criteria for
systemic sclerosis: An American college of Rheumatology/European
league against rheumatism collaborative initiative. Ann Rheum Dis.
72:1747–1755. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shiboski CH, Shiboski SC, Seror R,
Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H,
Vitali C, Bowman SJ, et al: 2016 American college of
Rheumatology/European league against rheumatism classification
criteria for primary sjögren's syndrome: A consensus and
data-driven methodology involving three International patient
cohorts. Arthritis Rheumatol. 69:35–45. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bohan A and Peter JB: Polymyositis and
dermatomyositis (first of two parts). N Engl J Med. 292:344–347.
1975.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tsujimoto Y, Kumasawa J, Shimizu S, Nakano
Y, Kataoka Y, Tsujimoto H, Kono M, Okabayashi S, Imura H and Mizuta
T: Doppler trans-thoracic echocardiography for detection of
pulmonary hypertension in adults. Cochrane Database Syst Rev.
5(CD012809)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang Q and Lu J: Analysis of the clinical
value of echocardiography and chest CT in the diagnosis of COPD
complicated with pulmonary hypertension. Chin J CT MRI. 18:88–90.
2020.(In Chinese).
|
|
22
|
Cheng H, Yu Z, Yan CL, Yang HD, Gao C and
Wen HY: Long-term efficacy and low adverse events of
methylprednisolone pulses combined to low-dose glucocorticoids for
systemic sclerosis: A retrospective clinical study of 10 years'
follow-up. J Inflamm Res. 15:4421–4433. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Panagiotou M, Church AC, Johnson MK and
Peacock AJ: Pulmonary vascular and cardiac impairment in
interstitial lung disease. Eur Respir Rev.
26(160053)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Schafer MJ, White TA, Iijima K, Haak AJ,
Ligresti G, Atkinson EJ, Oberg AL, Birch J, Salmonowicz H, Zhu Y,
et al: Cellular senescence mediates fibrotic pulmonary disease. Nat
Commun. 8(14532)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Khan SY, Awad EM, Oszwald A, Mayr M, Yin
X, Waltenberger B, Stuppner H, Lipovac M, Uhrin P and Breuss JM:
Premature senescence of endothelial cells upon chronic exposure to
TNFα can be prevented by N-acetyl cysteine and plumericin. Sci Rep.
7(39501)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kojima H, Kunimoto H, Inoue T and Nakajima
K: The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced
premature senescence in human fibroblasts. Cell Cycle. 11:730–739.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu D, Zeng F, Han L, Wang J, Yin Z, Lv L,
Guo L, Wang D, Xu Y and Zhou H: The synergistic action of phosphate
and interleukin-6 enhances senescence-associated calcification in
vascular smooth muscle cells depending on p53. Mech Ageing Dev.
182(111124)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang Z, Yang K, Zheng Q, Zhang C, Tang H,
Babicheva A, Jiang Q, Li M, Chen Y, Carr SG, et al: Divergent
changes of p53 in pulmonary arterial endothelial and smooth muscle
cells involved in the development of pulmonary hypertension. Am J
Physiol Lung Cell Mol Physiol. 316:L216–L228. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wakasugi T, Shimizu I, Yoshida Y, Hayashi
Y, Ikegami R, Suda M, Katsuumi G, Nakao M, Hoyano M, Kashimura T,
et al: Role of smooth muscle cell p53 in pulmonary arterial
hypertension. PLoS One. 14(e0212889)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
van der Feen DE, Bossers GPL, Hagdorn QAJ,
Moonen JR, Kurakula K, Szulcek R, Chappell J, Vallania F, Donato M,
Kok K, et al: Cellular senescence impairs the reversibility of
pulmonary arterial hypertension. Sci Transl Med.
12(eaaw4974)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Noureddine H, Gary-Bobo G, Alifano M,
Marcos E, Saker M, Vienney N, Amsellem V, Maitre B, Chaouat A,
Chouaid C, et al: Pulmonary artery smooth muscle cell senescence is
a pathogenic mechanism for pulmonary hypertension in chronic lung
disease. Circ Res. 109:543–553. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Roger I, Milara J, Belhadj N and Cortijo
J: Senescence alterations in pulmonary hypertension. Cells.
10(3456)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Alhamad EH, Cal JG, Alrajhi NN and Alharbi
WM: Predictors of mortality in patients with interstitial lung
disease-associated pulmonary hypertension. J Clin Med.
9(3828)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang H, Li J, Zhang Y and Li M: Effects
of pulmonary hypertension on physiological indexes in patients with
idiopathic pulmonary fibrosis. Clin Med Res Pract. 2:22–23,32.
2017.(In Chinese).
|
|
35
|
Marvisi M, Mancini C, Balzarini L and
Ramponi S: Red cell distribution width: A new parameter for
predicting the risk of exacerbation in COPD patients. Int J Clin
Pract. 75(e14468)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ren Q, Liu H, Wang Y, Dai D, Tian Z, Jiao
G and Liu X: The role of red blood cell distribution width in the
severity and prognosis of community-acquired pneumonia. Can Respir
J. 2021(8024024)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ozgul G, Seyhan EC, Özgül MA and Günlüoğlu
MZ: Red blood cell distribution width in patients with chronic
obstructive pulmonary disease and healthy subjects. Arch
Bronconeumol. 53:107–113. 2017.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
38
|
Rhodes CJ, Wharton J, Howard LS, Gibbs JS
and Wilkins MR: Red cell distribution width outperforms other
potential circulating biomarkers in predicting survival in
idiopathic pulmonary arterial hypertension. Heart. 97:1054–1060.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Förhécz Z, Gombos T, Borgulya G, Pozsonyi
Z, Prohászka Z and Jánoskuti L: Red cell distribution width in
heart failure: Prediction of clinical events and relationship with
markers of ineffective erythropoiesis, inflammation, renal
function, and nutritional state. Am Heart J. 158:659–666.
2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yang J, Liu C, Li L, Tu X and Lu Z: Red
blood cell distribution width predicts pulmonary hypertension
secondary to chronic obstructive pulmonary disease. Can Respir J.
2019(3853454)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang W, Liu J, Yang YH, Zhai ZG, Wang C
and Wang J: Red cell distribution width is increased in chronic
thromboembolic pulmonary hypertension. Clin Respir J. 10:54–60.
2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yıldız A, Kaya H, Ertaş F, Oylumlu M,
Bilik MZ, Yüksel M, Polat N, Akil MA, Atılgan Z and Ulgen MS:
Association between neutrophil to lymphocyte ratio and pulmonary
arterial hypertension. Turk Kardiyol Dern Ars. 41:604–609.
2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rezende SM, Lijfering WM, Rosendaal FR and
Cannegieter SC: Hematologic variables and venous thrombosis: Red
cell distribution width and blood monocyte count are associated
with an increased risk. Haematologica. 99:194–200. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lechartier B and Humbert M: Pulmonary
arterial hypertension in systemic sclerosis. Presse Med.
50(104062)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Humbert M, Morrell NW, Archer SL, Stenmark
KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O,
Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology
of pulmonary arterial hypertension. J Am Coll Cardiol. 43 (12 Suppl
S):13S–24S. 2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Harrison S, Vavken P, Kevy S, Jacobson M,
Zurakowski D and Murray MM: Platelet activation by collagen
provides sustained release of anabolic cytokines. Am J Sports Med.
39:729–734. 2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang ZJ, Wang HF, Lian TY, Zhou YP, Xu
XQ, Guo F, Wei YP, Li JY, Sun K, Liu C, et al: Human plasma IgG
N-Glycome profiles reveal a proinflammatory phenotype in chronic
thromboembolic pulmonary hypertension. Hypertension. 80:1929–1939.
2023.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lei Y, Zhang X, Feng Y, Wang J and Luo R:
Risk factors of pulmonary arterial hypertension in patients with
systemic lupus erythematosus. Cardiol Young. 31:1619–1624.
2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Jin Y, Guo G, Wang C and Jiang B:
Association of red cell distribution width with pulmonary arterial
hypertension in patients with mixed connective tissue disease. BMC
Pulm Med. 23(299)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chang B, Wigley FM, White B and Wise RA:
Scleroderma patients with combined pulmonary hypertension and
interstitial lung disease. J Rheumatol. 30:2398–2405.
2003.PubMed/NCBI
|
|
51
|
D'Andrea A, Stanziola A, Di Palma E,
Martino M, D'Alto M, Dellegrottaglie S, Cocchia R, Riegler L,
Betancourt Cordido MV, Lanza M, et al: Right ventricular structure
and function in idiopathic pulmonary fibrosis with or without
pulmonary hypertension. Echocardiography. 33:57–65. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Oliveira RKF, Waxman AB, Hoover PJ,
Dellaripa PF and Systrom DM: Pulmonary vascular and right
ventricular burden during exercise in interstitial lung disease.
Chest. 158:350–358. 2020.PubMed/NCBI View Article : Google Scholar
|
